Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Please note that all translations are automatically generated. Click here for the English version.
DOI :
10.3791/60504-v
January 28th, 2020
Chapters
0:04
Introduction
1:26
Circulating Mononuclear Progenitor Cell (MPC) Determination
4:03
Plasma Soluble Biomarker Determination
7:39
Results: Representative Coronary Progenitor Cell and Soluble Biomarker Analyses Before and After Coronary Angioplasty
9:01
Conclusion
冠状血管形成術後の心血管予後に影響を与える主要な有害心血管イベントの発症は、冠状動脈損傷および血管修復の程度に影響を受ける。新しい冠状動脈細胞および可溶性バイオマーカーの使用は、血管損傷および修復に反応し、MACEおよび予後の発達を予測するのに有用である。
Tags
-- Views
Related Videos
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit
Librarians
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
ABOUT JoVE
Leadership
Copyright © 2024 MyJoVE Corporation. All rights reserved